
Fasenra Pen Coupons & Savings Card – Discount Prices from $5814.67
My prescription
Edit
1ML of 30MG/ML, Fasenra Pen (1 Pen)
Select pharmacy

Rite Aid
$5814.67
COUPON PRICE
Walgreens
$6061.24
COUPON PRICEFasenra Pen savings card
Show this card to your pharmacist
Rite Aid
$5814.67
BIN
ID
PCN
GRP
019876
LHD858A226
CHIPPO
LHX
Powered by
Fasenra Pen dosage forms
Dosage | Quantity | Price from | Per unit |
---|---|---|---|
1ML of 30MG/ML | 1 Pen | $5814.67 | $5814.67 |
Fasenra Pen Side Effects
What is Fasenra pen for?
Fasenra Pen is used for the treatment of severe eosinophilic asthma in patients aged 12 years and older. It is an injectable medication that helps reduce the number of asthma attacks by targeting and reducing eosinophils, a type of white blood cell that contributes to asthma symptoms.
How much does a Fasenra pen cost?
The cost of a Fasenra pen can vary depending on factors such as the pharmacy, location, insurance coverage, and any available discounts or patient assistance programs. On average, without insurance, the price can range from approximately $4,000 to $5,000 per pen. It is advisable for individuals to check with their pharmacy or healthcare provider for the most accurate and up-to-date pricing information.
What are the uses of Fasenra?
Fasenra is used primarily for the treatment of severe eosinophilic asthma in adults and children aged 12 years and older. It is an add-on maintenance therapy designed to help reduce the number of asthma attacks and improve breathing in patients whose asthma is not well controlled with their current medications.
Why is Fasenra so expensive?
Fasenra is expensive due to several factors, including the costs associated with its research and development, clinical trials, and the complex manufacturing process. Additionally, it is a biologic medication, which typically involves more intricate production methods compared to traditional pharmaceuticals. The pricing also reflects the value it provides in treating severe eosinophilic asthma, a condition with limited treatment options. Market exclusivity and the costs of regulatory compliance can also contribute to its high price.
Does Fasenra improve lung function?
Yes, Fasenra (benralizumab) has been shown to improve lung function in patients with severe eosinophilic asthma. Clinical studies have demonstrated that patients receiving Fasenra experienced improvements in their lung function, as measured by forced expiratory volume in one second (FEV1), compared to those receiving a placebo. It is important for patients to discuss with their healthcare provider to determine if Fasenra is appropriate for their condition.